2026 FDA Status GLP-1 patches are not FDA-approved for weight loss or any medical condition
Read how our experts diagnose and treat hyperpigmentation here
Eur J Clin Pharmacol 50:45761 Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC, Herzenberg LA (1997) Glutathione deficiency is associated with impaired survival in HIV disease
The FDA has also raised concerns involving compounded GLP-1 products, including dosing errors, improper storage during shipping, fraudulent products, adverse event reports, and the use of semaglutide salt forms that the FDA has stated should not be used for compounding
Uncompromising Testing: Every batch undergoes rigorous third-party testing via HPLC and Mass Spectrometry to guarantee a purity profile of 99% or greater